Business

Change of Nominated Adviser and Broker

Change of Nominated Adviser and Broker.

Venture Life Group PlcNovember 14, 20235
Change of Nominated Adviser and Broker

About this update from Venture Life Group Plc

14 November 2023 VENTURE LIFE GROUP PLC ("Venture Life" "VLG" or the "Group") Change of Nominated Adviser and Broker Venture Life Group plc (AIM: VLG), a leader in developing, manufacturing and commercialising products for the self-care market, announces that, following the completion of the all share merger between Cavendish Securities plc (previously named Cenkos Securities plc) and Cavendish Financial plc (previously named finnCap Group plc), as a consequence of internal reorganisation within the Cavendish Group, the Company has changed its Nominated Adviser and Broker from Cavendish Securities plc to Cavendish Capital Markets Limited   For further information, please contact: Venture Life Group PLC                                                                                                    +44 (0) 1344 578004 Jerry Randall, Chief Executive Officer Daniel Wells, Chief Financial Officer   Cavendish Capital Markets Limited (Nomad and Broker)                                                 +44 (0) 20 7720 0500 Stephen Keys / Camilla Hume (Corporate Finance) Michael Johnson (Sales)   About Venture Life ( www.venture-life.com ) Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the global self-care market. With operations in the UK, Italy, The Netherlands and Sweden, the Group's product portfolio includes some key products such as the UltraDEX and Dentyl oral care product ranges, the Balance Active range in the area of women's intimate healthcare, the Lift and Glucogel product ranges for hypoglycaemia, products for fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing. Its products are sold in over 90 countries worldwide. The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples. In the UK and The Netherlands these are supplied direct by the company to retailers, elsewhere they are supplied by the Group's international distribution partners. Through its two Development & Manufacturing operations in Italy and Sweden, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.

View stock analysis, news, and events for Venture Life Group Plc

More from Venture Life Group Plc

All Venture Life Group Plc news →